TMPRSS2 and COVID-19: Hu et al. reported that tumor tissues in COVID-19 patients with TMPRSS2-ERG (T2E) alterations in metastatic TC may exhibit increased susceptibility to SARS-CoV-2 infection, thereby worsening prognosis [119].